FrancophonIA/ELRC3.0 huggingface dataset:
English: Valproat chrono Desitin 500mg Retardtabletten
Latvian: Valproat chrono Desitin 500mg Retardtabletten 500 mg
English: SODIUM VALPROATE TABLETS BP 500MG EC 500mg coated tablet
Latvian: SODIUM VALPROATE TABLETS BP 500MG EC
English: 145.14mg/333.3 mg prolonged-release granules
Latvian: 145,14 mg/333,3 mg ilgstošās darbības granulas
English: EPISENTA 500 MG PROLONGED-RELEASE GRANULES
Latvian: EPISENTA 500 MG PROLONGED
English: EPISENTA 150 MG PROLONGED-RELEASE CAPSULE
Latvian: RELEASE CAPSULE 150 mg ilgstošās darbības cietā kapsula
English: Valproat chrono Desitin 300 mg Retardtabletten
Latvian: Valproat chrono Desitin 300 mg Retardtabletten 300 mg
English: Czech Republic ratiopharm GmbH Graf-Arco-Straße 3 89079 Ulm Germany
Latvian: Čehijas Republika ratiopharm GmbH Graf-Arco-Straße 3 89079 Ulm Vācija
English: D-39116 Magdeburg Germany espa-valept 500 mg retard 500 mg esparma GmbH Seepark 7
Latvian: D-39116 Magdeburg Vācija espa-valept 500 mg retard 500 mg esparma GmbH Seepark 7
English: Convulex 300 mgFilmtabletten film-coated tablet
Latvian: Convulex 300 mgFilmtabletten apvalkotā tablete
English: EPIVAL CR 500MG PROLONGED RELEASE TABLETS
Latvian: EPIVAL CR 500MG PROLONGED
English: Sanofi-aventis GmbH SATURN Tower, Leonard-Bernstein-Str. 10 Vienna DC, A-1220 Wien Austria
Latvian: Sanofi-aventis GmbH SATURN Tower, Leonard-Bernstein-Str.
English: 200 mg sodium valproate and 87 mg valproic acid
Latvian: 200 mg nātrija valproāts un 87 mg valproiskābes
English: Natriumvalproat Desitin retard 150 mg prolonged-release capsule
Latvian: Natriumvalproat Desitin retard 150 mg ilgstošās darbības kapsula
English: VALPROSTAT 300MG 199.80 mg / 87.00 mg
Latvian: VALPROSTAT 300MG 199,80 mg / 87,00 mg ilgstošās darbības tablete
English: 5,764 /100 ml syrup
Latvian: 5,764 /100 ml sīrups
English: Depakine Zuur gastro-resistant capsule, soft
Latvian: Depakine Zuur zarnās šķīstoša mīkstā kapsula
English: Absenor 500 mg prolonged release tablets
Latvian: Absenor 500 mg prolonged release tablets 500 mg
English: DEPAKINE CHRONO 500 mg tablet
Latvian: DEPAKINE CHRONO 500 mg tablete
English: Absenor 300 mg prolonged release tablets
Latvian: Absenor 300 mg prolonged release tablets 300 mg
English: 57.64 mg/ml syrup
Latvian: 57,64 mg/ml sīrups
English: DEPAKINE ENTERIC 300mg tablet
Latvian: DEPAKINE ENTERIC 300 mg tablete
English: SODIUM VALPROATE ENTERIC COATED TABLETS 200MG
Latvian: SODIUM VALPROATE 200MG ENTERIC COATED TABLETS 200 mg
English: NATRIUMVALPROAATTI LONG DESITIN 500 mg/ dose prolonged-release granules
Latvian: NATRIUMVALPROAATTI LONG DESITIN 500 mg devā
English: D-39116 Magdeburg Germany espa-valept 150mg esparma GmbH Seepark 7
Latvian: D-39116 Magdeburg Vācija espa-valept 150mg esparma GmbH Seepark 7
English: 1000 mg/dose prolonged-release granules
Latvian: 1000 MG/ PACIŅĀ ilgstošās darbības granulas
English: 30 g oral drops, solution
Latvian: 30 g pilieni iekšķīgai lietošanai, šķīdums
English: 250 mg/dose prolonged-release granules
Latvian: 250 MG/ PACIŅĀ ilgstošās darbības granulas
English: 300 mg/5 ml syrup
Latvian: 300 mg/5 ml sīrups
English: Valproat HEXAL chrono 300 mg Retardtabletten
Latvian: Valproat HEXAL chrono 300 mg Retardtabletten 300 mg
English: Ergenyl Chronosphere 1000 mg Retardgranulat prolonged-release granules
Latvian: Ergenyl Chronosphere 1000 mg Retardgranulat
English: D-39116 Magdeburg Germany espa-valept 300 mg retard 300 mg esparma GmbH Seepark 7
Latvian: D-39116 Magdeburg Vācija espa-valept 300 mg retard 300 mg esparma GmbH Seepark 7
English: DEPAKINE ENTERIC 150mg tablet
Latvian: DEPAKINE ENTERIC 150 mg tablete
English: Convulex 300 mg gastroresistant capsules, soft gastro-resistant capsule, soft
Latvian: Convulex 300 mg gastroresistant capsules, soft zarnās šķīstoša mīkstā kapsula
English: Convulex 150 mg gastroresistant capsules, soft gastro-resistant capsule, soft
Latvian: Convulex 150 mg gastroresistant capsules, soft zarnās šķīstoša mīkstā kapsula
English: Natriumvalproat Desitin retard 300 mg prolonged-release capsule
Latvian: Natriumvalproat Desitin retard 300 mg ilgstošās darbības kapsula
English: Valproinsäure-ratiopharm ratiopharm GmbH D-89070 Ulm Germany
Latvian: Valproinsäure-ratiopharm ratiopharm GmbH D-89070 Ulm Vācija
English: DESITIN ARZNEIMITTEL GMBH Weg beim Jäger 214 Hamburgo D-22335
Latvian: DESITIN ARZNEIMITTEL GMBH Weg beim Jäger 214 Hamburgo D-22335 Vācija
English: SODIUM VALPROATE ENTERIC COATED TABLETS 500MG
Latvian: SODIUM VALPROATE 500MG ENTERIC COATED TABLETS 500 mg
English: Depakine 300 mgFilmtabletten film-coated tablet
Latvian: Depakine 300 mgFilmtabletten apvalkotā tablete
English: 333 mg + 145 mg prolonged-release filmcoated tablet
Latvian: 333 mg + 145 mg ilgstošās darbības apvalkotā tablete
English: EPISENTA 300 MG PROLONGED-RELEASE CAPSULE
Latvian: RELEASE CAPSULE 300 mg ilgstošās darbības cietā kapsula
English: Convulex 500 mg gastroresistant capsules, soft gastro-resistant capsule, soft
Latvian: Convulex 500 mg gastroresistant capsules, soft zarnās šķīstoša mīkstā kapsula
English: ORFIRIL LONG 300 mg 300 mg prolonged-release capsule
Latvian: ORFIRIL LONG 300 mg 300 mg ilgstošās darbības kapsula
English: Valproat HEXAL 300mg/ml Lösung oral solution
Latvian: Valproat HEXAL 300mg/ml Lösung šķīdums iekšķīgai lietošanai
English: Ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Germany
Latvian: Ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Vācija
English: ORFIRIL LONG 150 mg 150 mg prolonged-release capsule
Latvian: ORFIRIL LONG 150 mg 150 mg ilgstošās darbības kapsula
English: SODIUM VALPROATE LIQUID 200MG/5ML 200mg oral solution
Latvian: SODIUM VALPROATE LIQUID 200MG/5ML 200 mg šķīdums iekšķīgai lietošanai
English: 40 mg/ml syrup
Latvian: 40 mg/ml sīrups
English: Poland ratiopharm GmbH Graf-Arco-Strasse 3 Ulm89079
Latvian: Polija ratiopharm GmbH Graf-Arco-Strasse 3 Ulm89079
English: 666,60 sodium valproate and 290,27 mg valproic acid per sachet modified-release granules
Latvian: 666,60 nātrija valproāta un 290,27 mg valproiskābes paciņā
English: Valproat HEXAL chrono 500 mg Retardtabletten
Latvian: Valproat HEXAL chrono 500 mg Retardtabletten 500 mg
English: D-39116 Magdeburg Germany espa-valept 300mg esparma GmbH Seepark 7
Latvian: D-39116 Magdeburg Vācija espa-valept 300mg esparma GmbH Seepark 7
English: 333 mg sodium valproate and 145 mg valproic acid
Latvian: 333 mg nātrija valproāts un 145 mg valproiskābes
English: Valproat-CT 600 mg Filmtabletten neuraxpharm Arzneimittel GmbH u. Co.KG Elisabeth-Selbert-Str. 23 D-40764 Langenfeld Germany
Latvian: Co.KG Elisabeth-Selbert-Str. 23 D-40764 Langenfeld Vācija
English: Poland ratiopharm GmbH Graf-Arco-Strasse 3 Ulm 89079
Latvian: Polija ratiopharm GmbH Graf-Arco-Strasse 3 Ulm 89079
English: 200 mg/5 ml syrup
Latvian: 200 mg/5 ml sīrups
English: Convulex 200 mgKapseln gastro-resistant capsule, soft
Latvian: Convulex 200 mgKapseln zarnās šķīstoša mīkstā kapsula
English: Orfiril CR 150 mg modified-release capsule
Latvian: Orfiril CR 150 mg ilgstošās darbības kapsula
English: Depakine Chronosphere 100 mg modified-release granules
Latvian: DEPAKINE CHRONOSPHERE 100 MG Granulado de liberación modificada
English: 50mg/1ml syrup
Latvian: 50 mg/1 ml sīrups
English: Depakine Chronosphere 250 mg modified-release granules
Latvian: DEPAKINE CHRONOSPHERE 250 mg granulado de liberación modificada
English: Depakine Chronosphere 50350 mg/DosisRetardgranulat prolonged-release granules
Latvian: Depakine Chronosphere 50-350 mg/DosisRetardgranulat
English: 666,60 mg + 290,27 mg prolonged-release granules
Latvian: 666,60 mg + 290,27 mg
English: Depakine Chronosphere 750 mg modified-release granules
Latvian: DEPAKINE CHRONOSPHERE 750 MG Granulado de liberación modificada
English: Ergenyl Chronosphere 750 mg Retardgranulat prolonged-release granules
Latvian: Ergenyl Chronosphere 750 mg Retardgranulat
English: CONVULEX CR 300MG PROLONGED RELEASE TABLETS
Latvian: CONVULEX CR 300MG PROLONGED
English: Depakine Chrono 300 mg prolonged release tablets
Latvian: Depakine Chrono 300 mg prolonged release tablets 300 mg ilgstošas darbības tablete
English: 100 mg/ml syrup
Latvian: 100 mg/ml sīrups
English: SANOFI AVENTIS, S.A. Josep Plá, 2
Latvian: SANOFI AVENTIS, S.A.
English: 250mg/5ml syrup
Latvian: 250 mg/5 ml sīrups
English: Valproic Acid ER-APC 300 300 mg
Latvian: Valproic Acid ER-APC
English: Depakine Chronosphere 1000 mg - Retardgranulat in Beuteln prolonged-release granules
Latvian: Depakine Chronosphere 1000 mg - Retardgranulat in Beuteln
English: DEPAKINE CHRONOSPHERE 500 MG Granulado de liberación modificada modified-release granules
Latvian: DEPAKINE CHRONOSPHERE 500 MG Granulado de liberación modificada
English: 166,76 sodium valproate and 72,61 mg valproic acid per sachet modified-release granules
Latvian: 166,76 nātrija valproāta un 72,61 mg valproiskābes paciņā
English: DEPAKINE CHRONO 300mg tablet
Latvian: DEPAKINE CHRONO 300 mg tablete
English: Ergenyl Chronosphere 100 mg Retardgranulat prolonged-release granules
Latvian: Ergenyl Chronosphere 100 mg Retardgranulat
English: Depakine Chronosphere 50200 mg/DosisRetardgranulat prolonged-release granules
Latvian: Depakine Chronosphere 50-200 mg/DosisRetardgranulat
English: Depakine Chrono 500 mg prolonged release tablets
Latvian: Depakine Chrono 500 mg prolonged release tablets 500 mg ilgstošas darbības tablete
English: Depakine Chronosphere 750 mg - Retardgranulat in Beuteln prolonged-release granules
Latvian: Depakine Chronosphere 750 mg - Retardgranulat in Beuteln
English: NATRIUMVALPROAATTI LONG DESITIN 150 mg prolonged-release capsule, hard
Latvian: NATRIUMVALPROAATTI LONG DESITIN 150 mg ilgstošās darbības cietā kapsula
English: Ergenyl Chronosphere 250 mg Retardgranulat prolonged-release granules
Latvian: Ergenyl Chronosphere 250 mg Retardgranulat
English: Orfiril CR 300 mg modified-release capsule
Latvian: Orfiril CR 300 mg ilgstošās darbības kapsula
English: 33,33 sodium valproate and 14,51 mg valproic acid per sachet modified-release granules
Latvian: 33,33 nātrija valproāta un 14,51 mg valproiskābes paciņā
English: CONVULEX CR 500MG PROLONGED RELEASE TABLETS
Latvian: CONVULEX CR 500MG PROLONGED
English: Convulex gastro-resistant capsule Oral Use
Latvian: Convulex zarnās šķīstoša kapsula Iekšķīgai lietošanai
English: Depakine Chronosphere 100 mg - Retardgranulat in Beuteln prolonged-release granules
Latvian: Depakine Chronosphere 100 mg - Retardgranulat in Beuteln
English: Depakine Chronosphere 250 mg - Retardgranulat in Beuteln prolonged-release granules
Latvian: Depakine Chronosphere 250 mg - Retardgranulat in Beuteln
English: 333,30 sodium valproate and 145,14 mg valproic acid per sachet modified-release granules
Latvian: 333,30 nātrija valproāta un 145,14 mg valproiskābes paciņā
English: Valpro beta oral solution betapharm Arzneimittel GmbH Kobelweg 95
Latvian: Valpro beta šķīdums iekšķīgai lietošanai betapharm Arzneimittel GmbH Kobelweg 95
English: Ergenyl Chronosphere 50 mg Retardgranulat prolonged-release granules
Latvian: Ergenyl Chronosphere 50 mg Retardgranulat
English: 50 mg/ml syrup
Latvian: 50 mg/ml sīrups
English: Valproinsäure Valeant 300 300 mg
Latvian: Ácido Valpróico Generis 300 mg
English: 200.00 mg / 87.00 mg
Latvian: 200,00 mg / 87,00 mg ilgstošās darbības tablete
English: Ergenyl Chronosphere 500 mg Retardgranulat prolonged-release granules
Latvian: Ergenyl Chronosphere 500 mg Retardgranulat
English: Valproinsäure Valeant 600 600 mg ratiopharm GmbH D-89070 Ulm Germany
Latvian: Valproinsäure Valeant ratiopharm GmbH D-89070 Ulm Vācija
English: Convulex gastro-resistant capsule, soft
Latvian: Convulex zarnās šķīstoša mīkstā kapsula
English: capsule, hard
Latvian: cietā kapsula
English: Depakine Chronosphere 50 mg - Retardgranulat in Beuteln prolonged-release granules
Latvian: Depakine Chronosphere 50 mg - Retardgranulat in Beuteln
English: Depakine Chronosphere 500 mg - Retardgranulat in Beuteln prolonged-release granules
Latvian: Depakine Chronosphere 500 mg - Retardgranulat in Beuteln
English: Propymal Enteric 300 mg 300 mg gastro-resistant capsule, soft
Latvian: Propymal Enteric 300 mg 300 mg zarnās šķīstoša mīkstā kapsula
English: DEPAKINE ENTERIC 500mg tablet
Latvian: DEPAKINE ENTERIC 500 mg tablete
English: 100 mg/dose prolonged-release granules
Latvian: 100 MG/ PACIŅĀ ilgstošās darbības granulas
English: NATRIUMVALPROAATTI LONG DESITIN 300 mg prolonged-release capsule, hard
Latvian: NATRIUMVALPROAATTI LONG DESITIN 300 mg ilgstošās darbības cietā kapsula
English: DEPAKINE solución oral
Latvian: Depakine suikervrije stroop
English: Orfiril long 300 mg prolonged-release capsule
Latvian: Orfiril long 300 mg ilgstošās darbības cietā kapsula
English: MICROPAKINE LP
Latvian: MICROPAKINE LP 100 mg
English: Sanofi-Aventis France S.A. 1-13, boulevard Romain Rolland
Latvian: Sanofi-Aventis France S.A. 1-13, boulevard Romain Rolland 75014 Paris
English: Propymal Enteric 150 mg 150 mg gastro-resistant capsule, soft
Latvian: Propymal Enteric 150 mg 150 mg zarnās šķīstoša mīkstā kapsula
English: 220.00 mg/g / 96.00 mg/g prolonged-release granules
Latvian: 220,00 mg/g / 96,00 mg/g
English: VALPROATE SODIUM SANDOZ 300MG
Latvian: VALPROATE SODIUM SANDOZ 300MG 300 mg
English: VALPROATE SODIUM SANDOZ 500MG
Latvian: VALPROATE SODIUM SANDOZ 500MG 500 mg
English: Convulex 500 mgKapseln gastro-resistant capsule, soft
Latvian: Convulex 500 mgKapseln zarnās šķīstoša mīkstā kapsula
English: Orfiril long 150 mg prolonged-release capsule
Latvian: Orfiril long 150 mg ilgstošās darbības cietā kapsula
English: gastro-resistant capsule Oral Use
Latvian: zarnās šķīstoša kapsula Iekšķīgai lietošanai
English: Convulex 150 mgKapseln gastro-resistant capsule, soft
Latvian: Convulex 150 mgKapseln zarnās šķīstoša mīkstā kapsula
English: SANOFI AVENTIS FRANCE 1-13, boulevard Romain Rolland
Latvian: SANOFI AVENTIS FRANCE 1-13, boulevard Romain Rolland 75014 Paris
English: VALPROATE DE SODIUM RATIOPHARM L.P.
Latvian: RATIOPHARM L.P.
English: 500 mg/dose prolonged-release granules
Latvian: 500 MG/ PACIŅĀ ilgstošās darbības granulas
English: 333,30 mg + 145,14 mg prolonged-release granules
Latvian: 333,30 mg + 145,14 mg
English: ORFIRIL LONG 150 MG 150mg prolonged-release capsule, hard
Latvian: ORFIRIL LONG 150 MG 150 mg ilgstošās darbības cietā kapsula
English: Valproinsäure Valeant 300 Retard prolonged-reclease tablet
Latvian: Orfiril 300 retard ilgstošās darbības zarnās šķīstoša tablete Iekšķīgai lietošanai
English: 66,66 sodium valproate and 29,03 mg valproic acid per sachet modified-release granules
Latvian: 66,66 nātrija valproāta un 29,03 mg valproiskābes paciņā
English: CONVULEX 150 MG 150mg gastro-resistant capsule, soft
Latvian: CONVULEX 150 MG 150 mg zarnās šķīstoša mīkstā kapsula
English: Valproat-neuraxpharm chrono 300 mg neuraxpharm Arzneimittel GmbH u. Co.KG Elisabeth-Selbert-Str. 23 D-40764 Langenfeld Germany
Latvian: Valproat-neuraxpharm chrono 300 mg neuraxpharm Arzneimittel GmbH u.
English: ORFIRIL LONG 300 MG 300mg prolonged-release capsule, hard
Latvian: ORFIRIL LONG 300 MG 300 mg ilgstošās darbības cietā kapsula
English: 200 mg/ml oral solution
Latvian: DEPAKINE solución oral 200 mg/ml šķīdums iekšķīgai lietošanai
English: Convulsofin Tabletten tablet
Latvian: zarnās šķīstoša apvalkotā tablete
English: DEPAKINE CHRONO 300 200.00 mg / 87.00 mg
Latvian: 200,00 mg / 87,00 g ilgstošās darbības tablete
English: DEPAKINE ENTERIC 500 500 mg
Latvian: Ácido Valpróico Generis 500 mg
English: Convulex 300 mg - Kapseln 300 mg gastro-resistant capsule, soft
Latvian: CONVULEX 300 MG 300 mg zarnās šķīstoša mīkstā kapsula
English: Orfiril CR 1000 mg modified-release granules
Latvian: Orfiril CR 1000 mg
English: List of the names, pharmaceutical form(s), strength(s) of the medicinal product(s), route(s) of administration, applicant(s) in the Member States
Latvian: Zāļu nosaukumi, zāļu forma(-s), stiprums(-i), lietošanas veids(-i),
English: Pharmaceutical form
Latvian: Zāļu forma Lietošanas veids
English: Member State EU/EEA
Latvian: ES/EEA
English: Applicant company name, address
Latvian: Pietikuma iesniedzējs, adrese
English: (Invented) Name
Latvian: (Piešķirtais)
English: • At the request of the European Medicines Agency;
Latvian: • pēc Eiropas zāļu aģentūras pieprasījuma;
English: • if you are a child (less than 18 years of age), this medicine is not appropriate for you.
Latvian: • Ja jūs esat bērns (jaunāks par 18 gadiem), šīs zāles nav jums piemērotas.
English: 3.5 hours
Latvian: 3,5 stundas
English: INR increased d
Latvian: INR pieaugums d
English: Necessary preparations should be made to deal with this.
Latvian: Ir jāveic nepieciešamie sagatavošanās pasākumi.
English: Currently available data are described in sections 5.1 and 5.2.
Latvian: Pašlaik pieejamie dati aprakstīti 5.1. un 5.2. apakšpunktā Lietošanas veids
English: • before the start of the injection or infusion, the doctor will tell you about the signs of allergic reaction.
Latvian: • Pirms veikt injekciju vai infūziju, ārsts jums pastāstīs par alerģiskas reakcijas pazīmēm.
English: There is currently no indication for the use of Angiox in children less than 18 years old and no recommendation on a posology can be made.
Latvian: Šobrīd nav indikāciju par Angiox lietošanu bērniem, kas jaunāki par 18 gadiem, un ieteikumus par devām nevar sniegt.
English: Angiox is contraindicated in patients with:
Latvian: Angiox ir kontrindicēts pacientiem ar:
English: Compartment syndrome a, b
Latvian: Saspiešanas sindroms a, b
English: However, the maximal ACT values for all groups (adults and all paediatric groups) converge at a similar level near an ACT of 400 seconds.
Latvian: Tomēr maksimālās ACT vērtības visās grupās (pieaugušajiem un pediatrijas grupas) izlīdzinājās līdzīgā līmenī tuvu pie ACT 400 sekundēm.
English: From a microbiological point of view, the product should be used immediately.
Latvian: No mikrobioloģijas viedokļa zāles ir jāizlieto nekavējoties.
English: Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Latvian: Pirms zāļu lietošanas uzmanīgi izlasiet visu instrukciju, jo tā satur jums svarīgu informāciju
English: • if bleeding occurs (if this happens, treatment with Angiox will be stopped).
Latvian: • Ja notiek asiņošana (ja tā notiek, ārstēšana ar Angiox jāpārtrauc).
English: If you cannot get access to your doctor go immediately to the Emergency Department of your nearest hospital
Latvian: Ja Jūs nevarat sazināties ar savu ārstu, nekavējoties dodaties uz tuvākās slimnīcas Uzņemšanas nodaļu.
English: The educational materials will be used in all member states for both initial training and re-education in the event of reports of bolus only dosing without subsequent infusion.
Latvian: Izglītojošie materiāli visās dalībvalstīs tiks izmantoti gan sākotnējās, gan atkārtotas apmācības gadījumos, ja tiks saņemti ziņojumi par tikai bolus injekcijām, bez sekojošas infūzijas.
English: About 20% of bivalirudin is excreted unchanged in the urine.
Latvian: Aptuveni 20% bivalirudīna neizmainītā veidā izdalās ar urīnu.
English: • Whenever the risk management system is modified, especially as the result of new information being received that may lead to a significant change to the benefit/risk profile or as the result of an important (pharmacovigilance or risk minimisation) milestone being
Latvian: • ja ieviesti grozījumi riska pārvaldības sistēmā, jo īpaši gadījumos, kad saņemta jauna informācija, kas var būtiski ietekmēt ieguvumu/riska profilu, vai nozīmīgu (farmakovigilances vai riska mazināšanas) rezultātu sasniegšanas gadījumā
English: Bleeding Definitions
Latvian: Asiņošanas definīcijas
English: The bioavailability of bivalirudin for intravenous use is complete and immediate.
Latvian: Intravenozi ievadīta bivalirudīna biopieejamība ir pilnīga un tūlītēja.
English: Clearance (ml/min/kg)
Latvian: Klīrenss (ml/min/kg)
English: • if you are taking, or have recently taken or might take any other medicines.
Latvian: • par visām zālēm, kuras lietojat, pēdējā laikā esat lietojis vai varētu lietot;
English: Animal studies are insufficient with respect to effects on pregnancy, embryonal/foetal development, parturition or postnatal development (see section 5.3).
Latvian: Pētījumi ar dzīvniekiem nav pietiekami, lai novērtētu ietekmi uz grūtniecību, embrionālo/augļa attīstību, dzemdībām vai pēcdzemdību attīstību (skatīt 5.3. apakšpunktu).
English: All the undesirable effects, primary and secondary, resulting from excessive pharmacological activity were reversible.
Latvian: Visas nevēlamās, pārliekas farmakoloģiskās aktivitātes izraisītās blakusparādības, gan primārās, gan sekundārās, bija atgriezeniskas.
English: A total of 92.9% of patients treated underwent primary PCI as their primary management strategy.
Latvian: 92,2% pacientu tika veikta primārā PCI , jo tā viņiem bija izvēlētā kā primārā ārstēšanas stratēģija.
English: The majority of these cases were non-fatal.
Latvian: Vairumā gadījumu sekas nebija letālas.
English: This dosing regimen is required to achieve and maintain the plasma concentration required for effective ischaemic protection during PCI.
Latvian: Šāds dozēšanas režīms ir nepieciešams, lai sasniegtu un uzturētu plazmas koncentrāciju, kas nepieciešama efektīvai išēmiskai aizsardzībai PCI procedūras laikā.
English: • Tabulated information on dosing by body weight of patient.
Latvian: • Informācija tabulas veidā par dozēšanu atkarībā no pacienta ķermeņa svara.
English: Any unused solution should be discarded.
Latvian: Visi neizlietotie šķīdumi ir jāiznīcina.
English: An increase in the activated clotting time (ACT) may be used as an indication that a patient has received bivalirudin.
Latvian: Aktivētā recēšanas laika (ACT- activated clotting time) pieaugums var tikt izmantots kā rādītājs tam, ka pacients ir saņēmis bivalirudīnu.
English: • Brief information on preparation and administration instructions.
Latvian: • Informācijas kopsavilkums ar sagatavošanas un ievadīšanas instrukcijām.
English: Half-life (minutes)
Latvian: Pusperiods (minūtes)
English: The corresponding clearance is about 3.4  0.5 ml/min/kg.
Latvian: Atbilstošais klīrenss ir aptuveni 3,4  0,5 ml/min/kg.
English: If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
Latvian: Ja Jūs esat grūtniece vai barojat bērnu ar krūti, ja domājat, ka Jums varētu būt grūtniecība plānojat grūtniecību, pirms šo zāļu lietošanas konsultējieties ar ārstu.
English: See section 6.2 for the summary of compatible and incompatible concentrations of these compounds.
Latvian: Skatīt 6.2. apakšpunktu, kurā sniegts kopsavilkums par saderīgām un nesaderīgām šo zāļu koncentrāciju.
English: All 5 events were associated with additional cardiac procedures employing heparin anticoagulation (n=3) or with infections (n=2).
Latvian: Visi 5 notikumi bija saistīti ar papildu sirds procedūrām, kurās izmantoja heparīna antikoagulantu (n = 3), vai ar infekcijām (n = 2).
English: Bivalirudin is intended for short-term administration and therefore no data on the long-term carcinogenic potential of bivalirudin are available.
Latvian: Bivalirudīns ir paredzēts īslaicīgai lietošanai, tādēļ dati par bivalirudīna ilgtermiņa kancerogēno potenciālu nav pieejami.
English: Comparison of the single and repeated dose studies revealed that toxicity was related primarily to duration of exposure.
Latvian: Salīdzinot vienreizējas un atkārtotas devas, ir konstatēts, ka vielas toksicitāte pirmkārt ir saistīta ar tās iedarbības ilgumu.
English: • Bleeding and bruising at the puncture site (after PCI treatment) may be painful.
Latvian: • Asiņošana un zilums punkcijas vietā (pēc PCI) var būt sāpīgi.
English: Approximately 77% of patients had recurrent ischaemia, approximately 70% had dynamic ECG changes or elevated cardiac biomarkers, approximately 28% had diabetes and approximately 99% of patients underwent angiography within 72 hours.
Latvian: Aptuveni 77% pacientu bija atkārtota išēmija, aptuveni 70%- dinamiskas EKG izmaiņas vai paaugstināti sirds biomarķieri, aptuveni 28%- diabēts un apmēram 99% tikusi veikta angiogrāfija 72 stundu laikā.
English: The dosing cards will contain the following key information:
Latvian: Dozēšanas kartiņas ietvers šādu pamatinformāciju: